Synexus, a leading global network of research sites, is collaborating with the University of Exeter in the UK to launch one of the largest, registry-based research initiatives in the U.S. to help understand how healthy brains age.
The initial goal is to register 30,000 adults, aged 50 or older, without signs of dementia for a five-year study to examine lifestyle and genetic risk factors impacting cognitive function over time and to identify potential methods of prevention and possible treatments.
Synexus is collaborating with Acurian, a leading full-service provider of global patient enrollment, to help enroll study participants. Synexus and Acurian are members of Pharmaceutical Product Development, a global contract research organization.
“We hope to identify ways to prevent and treat dementia so people can maintain greater independence as they age,” Dr. Dawie Wessels, CMO of Synexus, said in a statement. “The registry provides a high level of engagement, pushing out relevant information about the latest advancements in dementia research and treatments, as well as brain-training games designed to help participants stay sharp,” he added.
The first Synexus study is being conducted on line, enabling people to participate in cognitive assessments, lifestyle and medical questionnaires, and brain-training exercises without leaving their homes.
In addition, participants will be among the first to learn about clinical trials of promising new treatments for Alzheimer’s and other forms of dementia.
